1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

ZytoMax GmbH

Have updates for this profile?  Please contribute data

About Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Dusseldorf Germany

Primary Industry

Medical Devices & Equipment

About

Based in Düsseldorf, Germany, ZytoMax GmbH operates as a holding company of Zytomed Systems GmbH, ZytoVision GmbH, and 42 Life Sciences GmbH & Co KG. The company develops, manufactures, and distributes cancer diagnostics tests and equipment such as in-situ hybridization (ISH) and immunohistochemistry (IHC) for clinical pathology labs in hospitals, clinics, and private practices.
Current Investors
ARCHIMED

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only

Deals

Deals Type
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed ZytoMax GmbH 12 Jan 2021
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo